CD Capital logo

CD Capital

Asia, Shanghai, China, Shanghai

Description

CD capital is a venture capital firm specialized in life sciences and medical technology.

Investor Profile

CD Capital has backed more than 7 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 43% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series D rounds (top funding stages).
  • Majority of deals are located in China, United States.
  • Strong thematic focus on Biotechnology, Health Care, Biopharma.

Stage Focus

  • Series B (29%)
  • Series A (29%)
  • Series D (29%)
  • Series Unknown (14%)

Country Focus

  • China (86%)
  • United States (14%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Genetics
  • Medical Device
  • 3d Printing
  • Manufacturing
  • Life Science
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CD Capital frequently co-invest with?

CICC
Asia, Beijing, China, Beijing
Co-Investments: 1
China Asset Management
Asia, Beijing, China, Beijing
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
ZWC Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
CL
Asia, Beijing, China, Beijing
Co-Investments: 1
Marathon Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Forebright Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
YC
North America, California, United States, San Francisco
Co-Investments: 2
ABC International
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 1

What are some of recent deals done by CD Capital?

Axon Therapies

New York, New York, United States

Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.

Health CareNeuroscienceTravel
Series ASep 25, 2025
Amount Raised: $32,000,000
Qihe Biotech

Suzhou, Jiangsu, China

Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

AgTechBiotechnologyGenetics
Series ADec 2, 2024
Amount Raised: $27,503,885
SprintRay

Los Angeles, California, United States

SprintRay is a 3D printer manufacturer that focuses on digital dentistry.

3D PrintingDentalHealth CareMedical Device
Series DOct 10, 2022
Amount Raised: $100,000,000
Xunshi Technology

Hangzhou, Zhejiang, China

Xunshi Technology is a professional engaged in 3D company.

3D Printing
Series DOct 9, 2022
Amount Raised: $100,000,000
Jenscare Biotech

Ningbo, Zhejiang, China

Ningbo Jenscare Scientific is a medical device company.

BiotechnologyHealth Care
Series UnknownMay 28, 2021
Hui-Gene Therapeutics

Shanghai, Shanghai, China

Hui-Gene is focused on R&D for single-gene disorders and has developed pilot pipes in neurodegenerative diseases.

BiopharmaBiotechnologyGeneticsLife ScienceMedicalMedical DevicePharmaceuticalTherapeutics
Series ADec 2, 2019
Amount Raised: $14,205,958
Shenzhen Kuaiyijian Network Technology

Shenzhen, Guangdong, China

Quiknos builds pharmaceutical cold-chain logistics systems.

Health Care
Series BJul 12, 2018
Amount Raised: $15,006,700
CMAB BioPharm

Suzhou, Jiangsu, China

CMAB BioPharm is a Biopharmaceutical Service Firm.

BiopharmaBiotechnologyManufacturing
Series BApr 2, 2018
Amount Raised: $34,000,000